Loading products…
Vaccines & Biologics
Powder for concentrate for solution for infusion
Kadcyla Powder for Concentrate for Solution for Infusion 160 mg 160 mg/8 ml needs a valid prescription.
Prescription-only — request it from licensed pharmacies near you. Add it to your request and we’ll ask pharmacies nearby to confirm availability and price; you review the offers and pay only if you accept. Have your prescription ready — you’ll present it at collection.
Request from pharmacies near youAvailable strengths: 160 mg/8 ml
Manufactured by Roche Products Limited
Composition: Kadcyla 160 mg powder for concentrate for solution for infusion. One vial of powder for concentrate for solution for infusion contains 160 mg of Trastuzumab emtansine. After reconstitution, one vial of 8 mL solution contains 20 mg/mL of Trastuzumab emtansine. * Trastuzumab emtansine is an antibody-drug conjugate that contains trastuzumab, a humanised IgG1 monoclonal antibody produced by mammalian (Chinese hamster ovary) cell suspension culture, covalently linked to DM1, a microtubule inhibitor, via the stable thioether linker MCC (4-[N-maleimidomethyl] cyclohexane-1-carboxylate)
Generic names: Trastuzumab emtansine
Always follow the product label. If symptoms persist, consult a pharmacist. Products are sold by licensed pharmacies near you.